Skip to content

United Therapeutics UTHR Inventory, Firm Purchase Commitment, Loss

Inventory, Firm Purchase Commitment, Loss at other companies

The Honest Company logo
The Honest CompanyHNST
$275K
ProFrac Holding Corp. logo
ProFrac Holding Corp.ACDC
$2.4M
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
$0-100%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$0+100%
Lucid Group, Inc. logo
Lucid Group, Inc.LCID
$228.32M+54.4%
The Beachbody Company logo
The Beachbody CompanyBODI
$595K+308%

Segments

By product

See full
Tyvaso DPI$26.8M

Other financials

Income statement

See full
Revenue$781.5M-1.6%
Gross profit$648.1M-7.7%
Operating income$325.8M-14.9%
Net income$274.9M-14.7%
EPS (diluted)$5.82-12.2%

Balance sheet

See full
Cash & equivalents$1.3B-32.6%
Total debt$12.2M
Total equity$5.9B-13.3%
Total assets$6.7B-13.3%

Cash flow

See full
Operating cash flow$463.3M+0.5%
CapEx$100.8M+34.6%
Free cash flow$362.5M-6.2%

Valuation

See full
Market cap$23B+84.1%
P/E17.9×+7.8×
P/S7.3×+3.2×

Profitability

See full
Gross margin86.6%-2.4pp
Operating margin45.3%-1.6pp
Net margin40.6%+0.2pp
FCF margin32.1%-5.6pp

Returns & leverage

See full
Return on equity20.3%+0.3pp
Debt / equity
Current ratio4.8×-0.7×